Expand
Updated
Millions of Americans are not taking GLP-1 drugs as prescribed, Ars Technica reported on November 13, 2026. Cost and access barriers are pushing people toward modified dosing and unapproved versions of the drugs.
Sources:Ars Technica
Updated
Millions of Americans are not taking GLP-1 drugs as prescribed, Ars Technica reported on November 13, 2026. Cost and access barriers are pushing people toward modified dosing and unapproved versions of the drugs.
1 outlet · 1 article · first seen Nov 13, 9:01 PM ET